Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | EXECUTIVE VICE PRESIDENT | February 28, 2023 | March 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 28, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 339,443 |
Reported balance
After 2023-02-28 transaction · row 1
1 source rowRow 1 · 2023-02-28 · Tax withholding · Disposed 6,247 · Balance 339,443 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $45.75 | $13,723.50 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 9 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,153 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,900 | $45.74 | $132,646.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 8 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,453 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $45.74 | $32,014.50 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 7 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,353 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,000 | $45.73 | $228,650.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 6 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,053 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.73 | $4,572.75 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 5 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,053 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $45.73 | $59,442.50 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 4 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,153 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,300 | $45.72 | $105,156.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 3 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,453 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.72 | $4,571.75 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,753 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $45.72 | $36,572.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,853 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $45.86 | $18,344.00 |
DisclosureSEC source: 0001179110-15-002009 · edgar.xml · nonDerivative · entry 9 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,945 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,200 | $45.85 | $100,870.00 |
DisclosureSEC source: 0001179110-15-002009 · edgar.xml · nonDerivative · entry 8 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,345 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $45.85 | $13,753.50 |
DisclosureSEC source: 0001179110-15-002009 · edgar.xml · nonDerivative · entry 7 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,545 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.84 | $4,583.75 |
DisclosureSEC source: 0001179110-15-002009 · edgar.xml · nonDerivative · entry 6 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,845 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $45.84 | $9,167.00 |
DisclosureSEC source: 0001179110-15-002009 · edgar.xml · nonDerivative · entry 5 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,945 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,935 | $45.83 | $88,681.05 |
DisclosureSEC source: 0001179110-15-002009 · edgar.xml · nonDerivative · entry 4 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,145 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.83 | $4,582.75 |
DisclosureSEC source: 0001179110-15-002009 · edgar.xml · nonDerivative · entry 3 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,080 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $45.83 | $36,660.00 |
DisclosureSEC source: 0001179110-15-002009 · edgar.xml · nonDerivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,180 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,900 | $45.82 | $178,698.00 |
DisclosureSEC source: 0001179110-15-002009 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,980 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 13,263 | $39.79 | $527,734.77 |
DisclosureSEC source: 0001179110-14-004313 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,945 Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 141,478 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003619 · edgar.xml · derivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,478 Underlying: Common shares · 141,478 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 47,160 on 2/21/2015, 47,159 on 2/21/2016, and 47,159 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 23,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003619 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,208 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 28, 2013 Filed Mar 2, 2013 00:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 15,105 | $34.26 | $517,497.30 |
DisclosureSEC source: 0001179110-13-003893 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,099 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 12,147 | $35.08 | $426,116.76 |
DisclosureSEC source: 0001179110-13-003134 · edgar.xml · nonDerivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,204 Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 22:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 149,600 | $0.00 Strike: $34.94 | $0.00 |
DisclosureSEC source: 0001179110-13-003134 · edgar.xml · derivative · entry 3 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,600 Underlying: Common shares · 149,600 shares Expires 2023-02-14 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 49,867 on 2/15/2014, 49,866 on 2/15/2015, and 49,867 on 2/15/2016. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 22:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 28,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003134 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,351 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $41.92 | $0.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · derivative · entry 25 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 100,000 shares Expires 2016-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,840 | $57.40 | $737,016.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 24 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,551 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,400 | $57.40 | $137,748.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 23 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,391 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 16,005 | $57.39 | $918,526.95 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 22 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,791 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $57.39 | $11,477.50 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 21 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,796 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,773 | $57.39 | $101,743.61 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 20 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,996 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 10,327 | $57.38 | $592,563.26 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 19 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,769 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,700 | $57.38 | $154,912.50 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 18 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,096 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,700 | $57.37 | $728,599.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 17 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,796 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $57.37 | $5,736.90 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 16 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,496 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $57.37 | $5,736.75 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 15 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,596 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $57.37 | $57,365.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 14 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,696 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,800 | $57.36 | $504,768.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 13 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,696 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $57.36 | $5,735.90 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 12 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,496 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,600 | $57.36 | $91,768.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 11 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,596 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,800 | $57.35 | $389,980.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 10 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,196 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $57.35 | $28,672.50 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 9 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,996 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,200 | $57.34 | $240,828.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 8 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,496 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $57.34 | $74,535.50 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 7 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,696 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,900 | $57.33 | $395,577.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 6 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,996 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $57.33 | $11,465.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 5 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,896 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,055 | $57.32 | $347,072.60 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 4 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,096 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $57.32 | $22,926.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 3 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,151 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,000 | $57.31 | $171,930.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,551 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 100,000 | $41.92 | $4,192,000.00 |
DisclosureSEC source: 0001179110-12-004525 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.